Member Info for TimmyTradeface

That's not what the charts are showing...

Fair enough if people are disappointed by the LOM but is it really possible that Kodal will do nothing else at all in the 8.5 years? If they're finally generating cash surely they'll do more exploration (this time not at the shareholders' expense) or maybe even have a go at starting up those gold mines BA is always harping on about.

That is quite encouraging. It was said phase I would conclude Q3 of 2019 in an RNS back in July. As far I am aware (correct me if I'm wrong) they haven't released an RNS to say the results of phase I - however, the clinical trials say 'Phase 1 has completed sufficient safety assessments at highest dose level. Protocol for phase 2 expansion is ongoing'. Does that mean we can expect an RNS in future confirming this?

I assume the 'suspended' business means they are waiting for the go ahead to commence phase II, I don't think we should be too worried about that.

Interesting contract award there. Wish they'd quoted the actual financials involved, seems a bit ambiguous but it's good news nevertheless.

Why do they keep setting such specific deadlines? They could just be more vague and say 'within the next few months' or 'in Q1' but they keep quoting ambitious dates and failing to deliver.

I think the company (hopefully) becoming financially independent is going to be the start of any meaningul rise. Good news seems just to bring in those who haven't researched the company and are either traders or people thinking the sp will continue to rise and they'll make a quick buck - they either take profit, or sell out when they get bored or worry about making a loss, leaving us long-term holders back at square one. Financial independence will potentially be a snowball effect; if they get one drug to market they should be able to self-fund all their other pipeline developments.

All the above is my opinion and interpretation of the situation. I could be completely wrong... DYOR!

I personally think things are back on their way up. They're at 73% utilisation for the whole of 2020, which is more than 2019 had at any point. If they can get a few more of their vessels chartered they should be able to start meeting future convenant tests and eventually paying off their debt. The new board seem to be working hard to turn things around.

I dont think it will rise. Lots of people jump on when they see the sp rise without really researching the company, then when the price begins to drop they all sell. Its happened everytime theres been good news.

It's doing great over in the states. Let's hope UK follows suit.

I guess this company isnt exciting anymore. I remember when any bit of good news was released, the price would go through the roof then come back down. Nowadays it basically does nothing. At least its positive news though - at the back of my mind I did worry that there was the potential the drug hadnt worked as effectively as they had hoped.

I'm at 6.9 average, but I will average down soon. I'd be happy for 8-9p at this rate...

I guess as long as they get the main two drugs to market we should profit in the end, even if its not such a spectacular rise as it could have been.

I didn't think the SP could go this low. People seem to be massively overreacting to the recent dilution, unless theres some other reason in unaware of. The sp now is the same, if not worse, than back in january when it did not have the funds to continue and seemed doomed to go bust (before the placing and CMS saved it). It's baffling.

I hope so too re: x110. They anticipated results by the end of Q3... we're a little beyond that now. Hopefully it will at least restore the sp to the pre-dilution level (though higher would be nice).

I don't fully understand why they are placing 60mil new shares on AIM as well, when the II bought the $3 millions worth on NASDAQ. Do they have to make sure that there is an equal number of shares issued on both markets?

It looks like the CFO has really shot himself in the foot here buying all those shares then causing the sp to plummet. I'm annoyed they released the orphan drug news after the calamitous fundraise; a little rally on that and I would have sold. I don't know if they thought releasing that the next day would soften the blow, but it clearly didn't.

If it was based on the US price then its not shockingly low. I think they've hung below our price for months. The bright side will be another 3 million dollars in the bank, but I just hope soon they start releasing news to get the sp back up again.

It that RNS the answer as to where Woody's shares ended up?

That's true enough, but with 201 they are commencing a phase I study (its not really news as they announced three weeks ago that they were going to be doing it), whereas with 110 we are now expecting the completion and results of a phase I study.

I think the next real good news we can expect is the mtx110 results, which were expected by the end of Q3 (so either they are late or they have not yet finished processing the results). I'm not sure the start of a new test is good enough news to warrant a significant rise but we shall see (and hope).